The Kudu by R82, a rigid frame, tilt-in-space reclining pediatric wheelchair, made its North American debut this week at the 33rd International Seating Symposium (ISS), held at the Gaylord Opryland Hotel and Convention Center, Nashville, TN.
The R82 Convaid business development team presented the Kudu along with other pediatric special needs products within the categories of mobility, walking, standing, seating, transportation and hygiene.
The Kudu was designed to offer easy and maneuverability. Available in four sizes, the Kudu is growth adaptable through the adjustable height back rest and adjustable depth seat. With -3° to 45° of tilt and -5° to 30° of recline, the self-centering, tilt-in-space Kudu maintains the child’s center of gravity, ensuring optimum balance and positioning. This feature allows for easy maneuvering and effortless tilting of the seat, even with the back reclined. Rear wheels are optimally positioned to enable self-propulsion.
The Kudu is highly customizable with many options, including head, trunk, foot and leg positioning options. The Kudu complies with ISO 7176-19 standards for safe transportation.
Director, Marketing Nanneke Dinklo and Executive Advisor Kieron Slocombe attended the annual event that attracts upwards of 2,000 attendees. Also on hand were R82 Convaid North America Sales Managers Charles Larose and Stephen Ricker; Business Development Representatives Sally Mallory, Barry Reidmiller, and Curtis Philyaw. It is the first year that R82 Convaid was joined by Etac, Immedia, Molift and Star Cushions at ISS.
“We are excited to present our tilt-in-space portfolio at ISS this year that consists of the new Kudu and improved Stingray, Rodeo and Trekker wheelchairs. The Kudu is a great complement to our line of mobility, seating, standing, walking, transportation and hygiene products and we look forward to demonstrating it at ISS. We equally look forward to learning about new developments in the seating and mobility community,” said Director, Marketing Nanneke Dinklo.
R82 Convaid develop and manufacture premium pediatric products typically prescribed for children with mild to moderate involvement of the following conditions: Autism Spectrum Disorder, Cerebral palsy, Down syndrome, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Spinal Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.